Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with medical imaging, such as PET and CT (“CAT”) scans. CT scans are often used to get detailed internal images to detect …
Read More »